Jazz Pharma's sleep disorder drug gets European panel backing
Jazz Pharmaceuticals Plc's treatment for a form of sleep disorder has been recommended for approval in Europe by a panel of the European Medicines Agency (EMA), the regulator said on Friday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: European Medicines Agency (EMA) | Health | Pharmaceuticals | Sleep Disorders | Sleep Medicine